标题 |
The DAVIO trial: a phase 1, open-label, dose escalation study of a single injection of EYP1901 (vorolanib in Durasert platform) demonstrating reduced treatment burden in wet age-related macular degeneration
DAVIO试验:一项单次注射EYP1901(Durasert平台中的vorolanib)的1期、开放标签、剂量递增研究,证明湿性年龄相关性黄斑变性的治疗负担降低
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | Investigative Ophthalmology and Visual Science 2023 64:8 (931) |
求助人 | |
下载 |